Study testing how to give meropenem in the ICU
Treatments studied
This pilot study looks at the best way to give meropenem antibiotic to ICU patients with a serious suspected or confirmed infection. It may help improve treatment timing and dosing to fight infection while in intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted to the ICU at Oslo University Hospital (Rikshospitalet)
- Have a serious suspected or confirmed infection that your care team plans to treat with meropenem
- You (or your next of kin) can provide written informed consent
- You do not have a known allergy to beta-lactam antibiotics (such as some penicillins or related drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This trial tests a way to give the antibiotic cefepime to ICU patients. It aims to see if the dosing can be adjusted more precisely for each person.
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
Hear when a new Drug Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.